Seed & Chemical
Bayer launches seed treatment for SDS
By Top Crop Manager
Bayer has launched ILeVO seed treatment, the first soybean seed treatment registered for Sudden Death Syndrome (SDS) in Canada.
SDS is caused by Fusarium virguliforme. This fungal pathogen overwinters on crop residue and is occurring more frequently in fields across Ontario. Difficult to identify and often misdiagnosed, the disease results in average annual yield loss of about 20 per cent, but can cause losses of up to 60 per cent in a growing season, according to a press release from Bayer. To date, there have been no seed treatment solutions available for SDS in Canada.
ILeVO has activity on the Fusarium virguliforme fungus. The company says the effectiveness of the product has been demonstrated through field trials in the U.S. and Canada over the past five years, including third-party trials with OMAFRA and the University of Guelph.
A feature unique to ILeVO which signals a successful application is the “halo effect,” which is often visible on the edges of the cotyledons of a treated plant.
For more information regarding ILeVO, growers are encouraged to talk to their local seed companies and retailers or visit cropscience.bayer.ca/ILeVO.